Amoy Diagnostics Co., Ltd. (300685.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Amoy Diagnostics Co., Ltd.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1175
First IPO Date
August 03, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Frank Ron Zheng | Deputy GM & Director | 0 | 1990 |
| Hongyu Wang | Deputy General Manager | 0 | 1984 |
| Huibin Zheng | Deputy General Manager | 0 | 1962 |
| Shuang Yang | Deputy General Manager | 0 | 1987 |
| Jiemin Luo | GM & Director | 0 | 1983 |
| Ruan Li | Deputy GM, Chief Technology Officer & Director | 0 | 1978 |
| Ying Chen | Chief Financial Officer, Accounting Supervisor & Secretary to the Board of Directors | 0 | 1970 |
AD
Description
Amoy Diagnostics Co., Ltd. is a Chinese company focused on oncology precision medicine. It engages in the research, development, production, and sale of molecular diagnostic products. The company provides a range of diagnostic reagents and testing services that help identify genetic mutations and biomarkers, which are used to guide personalized cancer treatment.
AD
